Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lauria

Showing results (71-80 of 219) with videos related to

Pageof 22
Sort By:
Haematologica|July 17, 2001
Long-term follow-up of human herpes virus 6 infection in autologous bone marrow transplant recipientsP Galieni, D Moschettini, D Donati, et al.
Haematologica|January 1, 1972
[Preliminary studies on the immunoreactivity of splenectomized patients with malignant granuloma]G Danieli, P L Malini, M Montroni, et al.
Infection|March 1, 1997
Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug usersF Montella, P Pezzotti, F Di Sora, et al.
Blood|March 1, 1997
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complicationsF Lauria, M Bocchia, G Marotta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: effectiveness and tolerabilityF Lauria, P L Zinzani, D Rondelli, et al.
Acta Haematologica|January 1, 1988
Septicaemia after splenectomy for Hodgkin's disease: two episodes in the same patient, 9 and 13 years after cureP Galieni, F Gherlinzoni, P Mazza, et al.
Giornale Di Clinica Medica|June 1, 1972
[Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma]G Danieli, P L Malini, M Montro NI, et al.
Haematologica|March 1, 1975
[Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)]F Lauria, M Baccarani, E Barbieri, et al.
Leukemia & Lymphoma|February 1, 1993
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivativesM Michieli, A Michelutti, D Damiani, et al.
Haematologica|August 24, 1999
Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomasM Bocchia, C Bigazzi, S Marconcini, et al.
Pageof 22

Showing results (71-80 of 219) with videos related to

Sort By:
Pageof 22
Haematologica|July 17, 2001
Long-term follow-up of human herpes virus 6 infection in autologous bone marrow transplant recipientsP Galieni, D Moschettini, D Donati, et al.
Haematologica|January 1, 1972
[Preliminary studies on the immunoreactivity of splenectomized patients with malignant granuloma]G Danieli, P L Malini, M Montroni, et al.
Infection|March 1, 1997
Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug usersF Montella, P Pezzotti, F Di Sora, et al.
Blood|March 1, 1997
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complicationsF Lauria, M Bocchia, G Marotta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: effectiveness and tolerabilityF Lauria, P L Zinzani, D Rondelli, et al.
Acta Haematologica|January 1, 1988
Septicaemia after splenectomy for Hodgkin's disease: two episodes in the same patient, 9 and 13 years after cureP Galieni, F Gherlinzoni, P Mazza, et al.
Giornale Di Clinica Medica|June 1, 1972
[Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma]G Danieli, P L Malini, M Montro NI, et al.
Haematologica|March 1, 1975
[Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)]F Lauria, M Baccarani, E Barbieri, et al.
Leukemia & Lymphoma|February 1, 1993
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivativesM Michieli, A Michelutti, D Damiani, et al.
Haematologica|August 24, 1999
Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomasM Bocchia, C Bigazzi, S Marconcini, et al.
Pageof 22